US 7,579,473 B2
c-Met modulators and methods of use
Lynne Canne Bannen, Pacifica, Calif. (US); Diva Sze-Ming Chan, San Francisco, Calif. (US); Timothy Patrick Forsyth, Hayward, Calif. (US); Richard George Khoury, Redwood City, Calif. (US); James William Leahy, San Leandro, Calif. (US); Morrisson B. Mac, San Francisco, Calif. (US); Larry W. Mann, Richland, Mich. (US); John M. Nuss, Danville, Calif. (US); Jason Jevious Parks, Sacramento, Calif. (US); Yong Wang, Foster City, Calif. (US); and Wie Xu, Danville, Calif. (US)
Assigned to Exelixis, Inc., South San Francisco, Calif. (US)
Filed on Feb. 26, 2009, as Appl. No. 12/393,806.
Application 12/393806 is a continuation of application No. 11/753514, filed on May 24, 2007.
Application 11/753514 is a continuation of application No. 11/586751, filed on Oct. 26, 2006.
Application 11/586751 is a continuation of application No. 10/573336, abandoned, previously published as PCT/US2004/031523, filed on Sep. 24, 2004.
Claims priority of provisional application 60/577384, filed on Jun. 04, 2004.
Claims priority of provisional application 60/535377, filed on Jan. 09, 2004.
Claims priority of provisional application 60/506181, filed on Sep. 26, 2003.
Prior Publication US 2009/0170896 A1, Jul. 02, 2009
Int. Cl. C07D 215/38 (2006.01); A61K 31/47 (2006.01)
U.S. Cl. 546—153  [514/312] 7 Claims
 
1. A compound according to formula XIVa:

OG Complex Work Unit Drawing
or a pharmaceutically acceptable salt thereof, wherein:
Q is CH; (R30)0-4 is (R30)0; R2 is halo; R20 is halo; and R50 is an unsubstituted C1-6alkyl group.